Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan

Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan

Abstract Objectives This study evaluated the cost‐effectiveness of delgocitinib relative to moisturization therapy in adult patients with moderate to severe atopic dermatitis. Methods The analysis was performed by using the simulation model with the patient‐level data from a phase 3 study and its lo...

Full description

Bibliographic Details
Main Authors: Motoi Takenaka, Mai Matsumoto, Hiroyuki Murota, Sachie Inoue, Hidetoshi Shibahara, Kazufumi Yoshida, Sotaro Takigawa, Atsushi Ishimoto
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Journal of Cutaneous Immunology and Allergy
Subjects:
atopic
cost‐benefit analysis
delgocitinib
dermatitis
quality‐adjusted life years
Online Access:https://doi.org/10.1002/cia2.12163

Internet

https://doi.org/10.1002/cia2.12163

Similar Items